Biocon subsidiary completes acquisition of Viatris' Global Biosimilars business for USD 3 billion30 Nov, 2022, 09.47 AM ISTLooking for a partner rather than acquisition in US market: BioconSC points Congress' Meenakshi Natarajan to EC remedy in nomination dispute
Watch: Sachin Tendulkar plays cricket mid-flight, gets caught by Sara and bowled by Saaniya Chandhok
UAE launches major digital upgrade for students and universities
Before Olympic glory, there was Jaspal Rana: Indian shooting loses its first star
After record IPO, Musk's SpaceX faces next test in market debut
BlackRock says oil, FX risks loom over India's bond inflow push
TCS launches India's first Oracle AI Data platform lab in Kolkata
Global Market | European stocks rally as oil falls on hopes for US-Iran deal
Bengal CM Suvendu Adhikari warns of being 'worst CM' if law & order breached
Beyond coriander and mint: 7 flavour-packed herbs from around the world you should grow for cooking
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service